Hot News @ 四環醫藥

 
Related Keyword:軒竹生物 , 四環醫藥 , 招股
Related Concept:四環醫藥分拆軒竹生物今起招股 , 四環醫藥分拆軒竹生物今 , 招股入場費 , 美國電動車銷售
 
軒竹生物孖展3960倍 下周三掛牌 @ 2025-10-12T
軒竹生物正積極開發超過十種藥物,包括KBP-3571(已獲NDA批准的治療消化系統疾病的創新質子泵抑制劑,即PPI)、XZP-3287(已獲NDA批准的靶向乳腺癌的細胞...
Keyword:軒竹生物
Concept:四環醫藥分拆軒竹生物今起招股
軒竹生物由四環醫藥分拆 5858元入場 抽定唔抽?認購前五個必知 @ 2025-10-11T
軒竹生物上市招股,這間由四環醫藥分拆、以創新為驅動的中國生物制藥公司,每手入場費約5858元,B仔股抽定唔抽?認購前五個必知。
Keyword:軒竹生物 四環醫藥 招股
Concept:四環醫藥分拆軒竹生物今起招股
新股追蹤亅軒竹生物孖展超購近2570倍 @ 2025-10-10T
生物科技板塊受資金追捧,由四環醫藥(00460)分拆、尚未盈利的生物制藥公司軒竹生物(02575)明日(10日)截飛,截至發稿前,券商暫時為其借出2007.73億元孖展,以公開發售集資...
Keyword:軒竹生物
Concept:四環醫藥分拆軒竹生物今 , 招股入場費
四環分拆軒竹生物一箭多雕 @ 2025-10-08T
近期,本港新股市場之中,生物科技股(俗稱「B仔股」)受到熱捧,主要是首日掛牌屢有好表現。轉型從事醫美的四環醫藥(00460)宣布分拆旗下生物制藥公司軒竹...
Keyword:軒竹生物 招股
Concept:美國電動車銷售
 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.